共 50 条
- [1] Treatment Persistence Among Bio-naive Patients with Crohn's Disease Initiated on Ustekinumab and Adalimumab AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S328 - S329
- [4] Long-Term Persistence to Ustekinumab and Adalimumab Among Bio-Naive Patients With Crohn's Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S571 - S572
- [5] Adalimumab was more effective in the patients with bio-naive and early Crohn's disease JOURNAL OF CROHNS & COLITIS, 2014, 8 : S305 - S305